ROSSARI BIOTECH LIMITED (ROSSARI) financials

ROSSARI BIOTECH LIMITED (ROSSARI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Rossari Biotech was started in 2003.They are among the largest manufacturersof textile specialty chemicals in India.[1]

Market Cap: ₹2,518Cr.
Current Price: ₹455
Stock P/E: 16.4
ROE: 11.1%
ROCE: 14.8%
Book Value: ₹232
Dividend Yield: 0.11%
52W High / Low: ₹675/373

In Sep 2026, ROSSARI BIOTECH LIMITED (ROSSARI) reported sales ₹495 Cr and net profit ₹34 Cr.

Annual TTM: sales ₹1,944 Cr, net profit ₹154 Cr.

Shareholding: Promoters 68.14% (Sep 2026), FIIs 1.84% (Sep 2026), DIIs 14.19% (Sep 2026), Public 15.84% (Sep 2026), No. of Shareholders 86,622% (Sep 2026).

ROSSARI quarterly results (₹ Cr.)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	368	427	366	420	451	516	482	495
Expenses	318	374	322	369	400	453	426	438
Operating Profit	50	52	44	50	50	64	56	57
OPM %	14%	12%	12%	12%	11%	12%	12%	12%
Other Income	1	2	2	1	1	23	2	2
Interest	2	3	3	2	4	4	4	2
Depreciation	7	8	7	7	7	9	8	11
Profit before tax	41	44	35	42	40	74	46	46
Tax %	26%	26%	26%	26%	24%	26%	26%	26%
Net Profit	31	32	26	31	31	55	34	34
EPS in Rs	5.53	5.84	4.74	5.64	5.53	9.88	6.19	6.18
Raw PDF	—	—	—	—	—	—	—	—

ROSSARI profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	600	690	1,073	975	1,203	1,432	1,752	1,944
Expenses	495	569	950	853	1,042	1,245	1,544	1,717
Operating Profit	105	121	123	123	161	186	208	228
OPM %	18%	18%	11%	13%	13%	13%	12%	12%
Other Income	4	10	13	4	7	6	27	28
Interest	4	3	3	5	10	10	13	14
Depreciation	17	22	26	26	24	28	31	36
Profit before tax	88	106	107	96	134	155	191	206
Tax %	26%	25%	26%	25%	26%	26%	25%	—
Net Profit	66	79	79	71	100	115	143	154
EPS in Rs	12.91	15.23	14.43	12.94	18.04	20.72	25.79	27.78
Dividend Payout %	4%	3%	3%	4%	3%	2%	2%	—

ROSSARI balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
Equity Capital	10	10	11	11	11	11	11	11
Reserves	273	394	774	848	949	1,066	1,207	1,275
Borrowings	67	0	0	65	68	50	144	101
Other Liabilities	118	140	141	202	253	324	401	412
Total Liabilities	468	544	926	1,126	1,281	1,451	1,764	1,799
Fixed Assets	94	171	177	157	167	179	218	255
CWIP	22	0	1	14	25	34	105	79
Investments	15	9	381	493	528	538	548	543
Other Assets	338	364	367	462	561	699	893	923
Total Assets	468	544	926	1,126	1,281	1,451	1,764	1,799

ROSSARI cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	72	56	52	33	113	74	92	59
Cash from Investing Activity	-41	-187	-37	-318	-160	-70	-70	-102
Cash from Financing Activity	-26	155	-29	297	61	-22	-32	79
Net Cash Flow	5	23	-14	12	14	-18	-10	36
Free Cash Flow	28	-20	-4	3	92	24	39	-36
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	118%	72%	68%	47%	112%	68%	71%	53%

ROSSARI shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	68.19%	68.18%	68.18%	68.18%	68.15%	68.15%	68.14%	68.14%
FIIs	3.74%	3.98%	3.48%	2.70%	2.32%	2.18%	2.03%	1.84%
DIIs	17.47%	17.59%	17.84%	18.18%	18.25%	18.21%	14.64%	14.19%
Public	10.60%	10.24%	10.50%	10.95%	11.25%	11.46%	15.19%	15.84%
No. of Shareholders	95,735	92,852	91,791	91,387	89,249	86,972	87,580	86,622

ROSSARI key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	61	57	73	62	91	92	96	108
Inventory Days	59	57	72	48	58	61	62	50
Days Payable	114	95	100	52	92	92	100	102
Cash Conversion Cycle	6	19	44	58	58	61	58	56
Working Capital Days	20	22	61	63	52	67	72	61
ROCE %	55%	38%	29%	18%	12%	14%	15%	15%

ROSSARIUpdated 18 Oct 2026, 17:57

Rossari Biotech Limited

ROSSARIUpdated 18 Oct 2026, 17:57

Market Cap

₹2,518Cr.

Current Price

₹455

High / Low

₹675/373

Stock P/E

16.4

ROE11.1%

ROCE14.8%

Book Value₹232

Face Value₹2.00

Dividend Yield0.11%

About

Rossari Biotech was started in 2003.They are among the largest manufacturersof textile specialty chemicals in India.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Sep 2023	332	3	290	2	6	36	26	26	4.78
Dec 2023	299	3	258	2	6	35	27	26	4.62
Mar 2024	314	2	272	1	7	35	25	26	4.74
Jun 2024	301	2	261	1	6	33	26	24	4.4
Sep 2024	336	2	292	1	7	37	26	27	4.96
Dec 2024	368	2	318	1	7	41	26	31	5.53
Mar 2025	427	3	374	2	8	44	26	32	5.84
Jun 2025	366	3	322	2	7	35	26	26	4.74
Sep 2025	420	2	369	1	7	42	26	31	5.64
Dec 2025	451	4	400	1	7	40	24	31	5.53
Mar 2026	516	4	453	23	9	74	26	55	9.88
Jun 2026	482	4	426	2	8	46	26	34	6.19
Sep 2026	495	2	438	2	11	46	26	34	6.18

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2011	122	3	108	0	5	6	11	5	1.05
Mar 2016	178	3	166	0	4	5	29	3	0.71
Mar 2017	233	2	209	1	4	19	17	16	3.22
Mar 2018	292	1	247	1	5	39	27	29	5.98
Mar 2019	516	3	438	1	12	63	28	46	9.46
Mar 2020	600	4	495	4	17	88	26	66	12.91
Mar 2021	690	3	569	10	22	106	25	79	15.23
Mar 2022	1073	3	950	13	26	107	26	79	14.43
Mar 2023	975	5	853	4	26	96	25	71	12.94
Mar 2024	1203	10	1042	7	24	134	26	100	18.04
Mar 2025	1432	10	1245	6	28	155	26	115	20.72
Mar 2026	1752	13	1544	27	31	191	25	143	25.79
TTM	1944	14	1717	28	36	206	—	154	27.78

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	68.14%
FIIs	1.84%
DIIs	14.19%
Public	15.84%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	68.34%	4.14%	18.06%	9.45%
Mar 2024	68.32%	4.02%	17.74%	9.9%
Jun 2024	68.32%	3.83%	16.87%	10.98%
Sep 2024	68.27%	3.74%	17.34%	10.64%
Dec 2024	68.19%	3.74%	17.47%	10.6%
Mar 2025	68.18%	3.98%	17.59%	10.24%
Jun 2025	68.18%	3.48%	17.84%	10.5%
Sep 2025	68.18%	2.7%	18.18%	10.95%
Dec 2025	68.15%	2.32%	18.25%	11.25%
Mar 2026	68.15%	2.18%	18.21%	11.46%
Jun 2026	68.14%	2.03%	14.64%	15.19%
Sep 2026	68.14%	1.84%	14.19%	15.84%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2011	4	27	38	24	93	43	0	0	50	93
Mar 2016	4	41	22	37	104	36	8	0	60	104
Mar 2017	4	56	24	37	122	37	8	0	77	122
Mar 2018	4	85	22	49	160	44	10	3	103	160
Mar 2019	4	116	9	119	248	74	3	0	171	248
Mar 2020	10	273	67	118	468	94	22	15	338	468
Mar 2021	10	394	0	140	544	171	0	9	364	544
Mar 2022	11	774	0	141	926	177	1	381	367	926
Mar 2023	11	848	65	202	1126	157	14	493	462	1126
Mar 2024	11	949	68	253	1281	167	25	528	561	1281
Mar 2025	11	1066	50	324	1451	179	34	538	699	1451
Mar 2026	11	1207	144	401	1764	218	105	548	893	1764
Sep 2026	11	1275	101	412	1799	255	79	543	923	1799

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2011	0	0	0	0
Mar 2016	23	-5	-18	1
Mar 2017	2	-6	3	0
Mar 2018	22	-16	-6	-1
Mar 2019	72	-41	-26	5
Mar 2020	56	-187	155	23
Mar 2021	52	-37	-29	-14
Mar 2022	33	-318	297	12
Mar 2023	113	-160	61	14
Mar 2024	74	-70	-22	-18
Mar 2025	92	-70	-32	-10
Mar 2026	59	-102	79	36

Key ratios

Historical financial ratios

Category	Mar 2011	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	70	59	74	75	61	57	73	62	91	92	96	108
Inventory Days	77	70	52	65	59	57	72	48	58	61	62	50
Days Payable	83	79	70	71	114	95	100	52	92	92	100	102
Cash Conversion Cycle	63	50	56	69	6	19	44	58	58	61	58	56
Working Capital Days	78	11	23	42	20	22	61	63	52	67	72	61
ROCE %	—	—	27%	42%	55%	38%	29%	18%	12%	14%	15%	15%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ROSSARI BIOTECH LIMITED (ROSSARI)?

The reported market capitalisation for ROSSARI BIOTECH LIMITED (ROSSARI) is ₹2,518Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ROSSARI?

The current price shown for ROSSARI BIOTECH LIMITED (ROSSARI) on Fincrux is ₹455 with a 52-week high/low of ₹675/373.

What is the P/E ratio of ROSSARI BIOTECH LIMITED (ROSSARI)?

The stock P/E for ROSSARI BIOTECH LIMITED (ROSSARI) is 16.4 on Fincrux, with ROE at 11.1% and ROCE at 14.8%.

What were ROSSARI latest quarterly results?

For Sep 2026, ROSSARI BIOTECH LIMITED (ROSSARI) reported sales ₹495 Cr and net profit ₹34 Cr (figures in ₹ crore unless noted).

What are ROSSARI annual sales and net profit?

For TTM, ROSSARI BIOTECH LIMITED (ROSSARI) shows sales of ₹1,944 Cr and net profit of ₹154 Cr on the Fincrux profit & loss statement.

Who owns ROSSARI BIOTECH LIMITED (ROSSARI)?

Latest shareholding for ROSSARI BIOTECH LIMITED (ROSSARI) on Fincrux: Promoters 68.14% (Sep 2026), FIIs 1.84% (Sep 2026), DIIs 14.19% (Sep 2026), Public 15.84% (Sep 2026), No. of Shareholders 86,622% (Sep 2026).

Where can I find ROSSARI BIOTECH LIMITED (ROSSARI) financials?

ROSSARI BIOTECH LIMITED (ROSSARI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ROSSARI balance sheet and cash flow?

Yes. The ROSSARI BIOTECH LIMITED (ROSSARI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 17:57